exenatide SR two week formulation (PT302) / Peptron  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
exenatide SR two week formulation (PT302) / Peptron
NCT01507038: Safety and Efficacy of YH14617 in Diabetes Mellitus

Completed
2
84
RoW
YH14617, Placebo
Yuhan Corporation, Peptron, Inc.
Diabetes Mellitus
01/15
02/15

Download Options